HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ipilimumab in prostate cancer.

AbstractINTRODUCTION:
Immune checkpoint inhibitors, such as ipilimumab , are a new class of immunotherapeutic agents that have shown significant efficacy in melanoma. A number of ongoing clinical trials are investigating the role of ipilimumab in prostate cancer, either alone or in combination with immunomodulating agents such as radiation and chemotherapy, and in combination with cancer vaccines.
AREAS COVERED:
This article reviews the molecular basis, preclinical and clinical evidence on the safety and efficacy of ipilimumab in prostate cancer. Medical literature search using MEDLINE and online abstracts database of national meetings form the basis of this article.
EXPERT OPINION:
A number of preliminary clinical studies suggest the potential therapeutic utility of immune checkpoint inhibitors such as ipilimumab in prostate cancer. Pending the results of large-scale studies, the rationale of combining ipilimumab with standard anticancer therapeutics such as radiation, cytotoxic chemotherapy and other immunotherapeutic agents can be of great value in reducing mortality and morbidity in prostate cancer.
AuthorsNishith Singh, Ravi A Madan, James L Gulley
JournalExpert opinion on biological therapy (Expert Opin Biol Ther) Vol. 13 Issue 2 Pg. 303-13 (Feb 2013) ISSN: 1744-7682 [Electronic] England
PMID23265575 (Publication Type: Journal Article, Research Support, N.I.H., Intramural, Review)
Chemical References
  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • CTLA-4 Antigen
  • Ipilimumab
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Antineoplastic Agents (therapeutic use)
  • CTLA-4 Antigen (immunology)
  • Combined Modality Therapy
  • Drug Evaluation, Preclinical
  • Humans
  • Ipilimumab
  • Male
  • Prostatic Neoplasms (drug therapy, radiotherapy)
  • T-Lymphocytes, Cytotoxic (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: